ALX Oncology Holdings Inc.
ALXO
$2.19
$0.041.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.38M | 5.09M | 5.45M | 7.93M | 7.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.02M | 22.53M | 23.47M | 31.82M | 30.61M |
| Operating Income | -23.02M | -22.53M | -23.47M | -31.82M | -30.61M |
| Income Before Tax | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M |
| EBIT | -23.02M | -22.53M | -23.47M | -31.82M | -30.61M |
| EBITDA | -22.87M | -22.38M | -23.28M | -31.61M | -30.40M |
| EPS Basic | -0.42 | -0.41 | -0.49 | -0.58 | -0.55 |
| Normalized Basic EPS | -0.26 | -0.26 | -0.27 | -0.36 | -0.35 |
| EPS Diluted | -0.42 | -0.41 | -0.49 | -0.58 | -0.55 |
| Normalized Diluted EPS | -0.26 | -0.26 | -0.27 | -0.36 | -0.35 |
| Average Basic Shares Outstanding | 54.28M | 53.58M | 53.45M | 53.36M | 52.80M |
| Average Diluted Shares Outstanding | 54.28M | 53.58M | 53.45M | 53.36M | 52.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |